ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
Clinical trial NCT07454226 · RECRUITING
Trial details
- NCT number
- NCT07454226
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-30
- Primary completion
- 2028-03-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.